{
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "document": {
    "pdf_name": "CDC_Influenza_vaccines",
    "source_pdf": "data/clinical_files/CDC Influenza vaccines.pdf",
    "total_pages": 2,
    "total_blocks": 23,
    "total_characters": 2237
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 1,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "RIV4 (recombinant HA vaccine)",
      "relevance_explanation": "This quote identifies the recombinant HA vaccine (RIV4), which is relevant because the claim compares the antibody response of higher-dose recombinant flu vaccines to standard-dose egg-based vaccines."
    }
  ],
  "model_used": "gpt-4.1"
}